Atrial Fibrillation in the 21st Century: The New Cardiac ‘Cinderella’ and New Horizons for Cardiovascular Nursing?

[1] Garg R. Packer M. Pitt B. Yusuf S. Heart failure in the 1990s; evolution of a major public health problem in cardiovascular medicine J. Am. Coll. Cardiol. 22 1993 3A–5A

[2] Stewart S. The future burden of chronic cardiac disease states—implications for nursing practice Eur. J. Cardiov. Nursing 1 2002 11–15

[3] McMurray J.J. Hart W. Rhodes G. An evaluation of the cost of heart failure to the National Health Service in the UK Br. J. Med. Econ. 6 1993 91–98

[5] Stewart S. MacIntyre K. McCleod M.E. Bailey A.E. Capewell S. McMurray J.J. Trends in heart failure hospitalisations in Scotland, 1990–1996: an epidemic that has reached its peak? Eur. Heart J. 22 2001 209–217

[6] Bonneux L. Barendregt M.A. Meeter K. Bonsel G.J. van der Maas P.J. Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: the future rise of heart failure Am. J. Public Health 84 1994 20–28

[8] Morrison C. McMurray J.J. Heart failure: the Cinderella of cariology? Public Health 111 1997 351–354

[9] Ezekowitz M.D. Atrial fibrillation: the epidemic of the new millennium Ann. Intern. Med. 131 1999 537–538

[10] Chugh S.S. Blackshear J.L. Shen W.K. Hammill S.C. Gersh B.J. Epidemiology and natural history of atrial fibrillation: clinical implications J. Am. Coll. Cardiol. 37 2001 371–378

[11] Lip G.Y. Golding D.J. Nazir M. A survey of atrial fibrillation in general practice: The West Birmingham Atrial Fibrillation Project Br. J. Gen. Pract. 47 1997 285–289

[12] Sudlow M. Thomson R. Thwaites R. Rodgers H. Kenny R.A. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community Lancet 352 1998 1167–1171

[13] Majeed A. Moser K. Carrol K. Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994–1998: analysis of data from the general practice research database Heart 86 2001 284–288

[14] Stewart S. Hart C.L. Hole D.A. McMurray J.J.V. Population prevalence, incidence and predictors of atrial fibrillation in the Renfrew/Paisley study Heart 86 2001 516–521

[15] Stewart S. MacIntyre K. Boyd J. Trends in first-ever admissions for atrial fibrillation in Scotland 1985–1995 Int. J. Cardiol. 82 2002 229–236

[16] Stewart S. MacIntyre K. McCleod M.C. Bailey A.E. McMurray J.J.V. Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland 1986–1996 Eur. Heart J. 22 2001 693–701

[17] MacIntyre K. Capewell S. Stewart S. Evidence of improving prognosis in heart failure: trends in case-fatality in 66,547 patients hospitalised between 1986 and 1995 Circulation 102 2000 1126–1131

[18] Frost L. Engholm G. Moller H. Husted S. Decrease in mortality in patients with a hospital diagnosis of atrial fibrillation in Denmark during the period 1980–1993 Eur. Heart J. 20 1999 1592–1599

[20] Batchelor W.B. Jollis J.G. Friesinger G.C. The challenge of health care delivery to the elderly patient with cardiovascular disease. Demographic, epidemiologic, fiscal and health policy implications Cardiol. Clin. 17 1999 1–15

[21] Tunstall-Pedoe H. Kuulasmaa K. Mahonen M. Tolonen H. Ruokokoski E. Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease Lancet 353 1999 1547–1557

[22] Capewell S. Livingston B.M. MacIntyre K. Trends in case-fatality in 117,718 patients admitted with acute myocardial infarction in Scotland Eur. Heart J. 2000 1833–1840

[23] Capewell S. MacIntyre K. Stewart S. Age, sex and social trends in out-of-hospital cardiac deaths in Scotland 1986–1995: a retrospective cohort study Lancet 358 2001 1213–1217

[24] Ryder K.M. Benjamin J.L. Shen W.K. Epidemiology and natural history of atrial fibrillation: clinical implications J. Am. Coll. Cardiol. 37 2001 371–378

[25] Kannel W.B. Abbot R.D. Savage D.D. Epidemiological features of chronic atrial fibrillation The Framingham study N. Engl. J. Med. 306 1982 1018–1024

[26] Wolf P. Abbot R.D. Kannel W.B. Impact of atrial fibrillation on mortality, stroke and medical costs Arch. Intern. Med. 158 1998 229–234

[27] Hart R. Benavente O. McBride R. Pearce L. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis Ann. Intern. Med. 131 1999 492–503

[29] SPAF-II Study Investigators Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: SPAF-II Study Lancet 343 1994 687–691

[31] Watzke H.H. Forberg E. Svolba G. Jimenez-Boj E. Krinninger G. A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation Thromb. Haemost. 83 2000 661–665

[32] Wyse D.G. The AFFIRM trial: main trial and substudies—what can we expect? J. Interv. Card. Electrophysiol. 4 Suppl 1 2000 171–176

[33] Izumoto H. Kawazoe K. Eishi K. Kamata J. Medium-term results after the modified Cox/Maze procedure combined with other cardiac surgery Eur. J. Cardiothorac. Surg. 17 2000 25–29

[34] Swerdlow C.D. Schsls W. Dijkman B. Detection of atrial fibrillation and flutter by a dual-chamber implantable cardioverter–defibrillator Circulation 101 2000 878–885

[35] Stroke Prevention in Atrial Fibrillation Committee on Echocardiography Transoesophageal echocardiographic correlates of thromboembolism in high risk patients with atrial fibrillation Ann. Intern. Med. 128 1998 639–647

[36] Berry C. Stewart S. Payne E.M. Electrical cardioversion for atrial fibrillation: outcomes in ‘real life’ clinical practice Int. J. Cardiol. 81 2001 29–35

[37] Rosendal F.R. The Scylla and Charybdis of oral anticoagulant treatment N. Engl. J. Med. 335 1996 587–589

[38] Gaughan G.L. Dolan C. Wilk-Rivard E. Improving management of atrial fibrillation and anticoagulation in a community hospital Comm. J. Qual. Improv. 26 2000 18–28

[39] Peterson G.M. Boom K. Jackson S.L. Vial J.H. Doctor's beliefs on the use of antithrombotic therapy in atrial fibrillation: identifying barriers to stroke prevention Intern. Med. J. 32 2002 15–23

[40] Tonkin A. Non-rheumatic fever and stroke Aust. NZ J. Med. 29 1999 467–472

[41] Lip G.Y. The prothrombotic state in atrial fibrillation: new insights, more questions and clear answers needed Am. Heart J. 140 2000 348–350

[42] Lip G.Y. Does atrial fibrillation confer a hypercoagulable state? Virchow's triad revisited J. Am. Coll. Cardiol. 33 1999 1424–1426

[43] Ridker P.M. Hennekens C.H. Lindpaintner K. Polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis Lancet 349 1999 385–388

[44] Rosendaal F.R. Siscovick D.S. Schwartz S.M. A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women Blood 90 1997 1447–1450

[45] Stewart S. Pearson S. Uncovering a multitude of sins: medication management in the home post acute hospitalisation among the chronically ill Aust. NZ J. Med. 29 1999 220–227

[47] McMurray J.J. Stewart S. Epidemiology, aetiology and prognosis of heart failure Heart 5 2000 596–602

[48] Stromberg A. Martensson J. Fridlund B. Dahlstrom U. Nurse-led heart failure clinics in Sweden Eur. J. Heart Fail. 2001 139–144

[49] Sawicki P.T. A structured teaching and self-management program for patients receiving oral anticoagulation: a randomised controlled trial JAMA 281 1999 145–150

[50] Thompson D.R. Stewart S. The role of nurse-led interventions in coronary heart disease management Eur. J. Cardiov. Nursing 1 2001 7–11